CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 4,216 enrolled
Drug / intervention
3-dimensional conformal accelerated partial breast irradiation +3 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00103181
NCT00103181N/ACompleted

A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women With Stage 0, I, or II Breast Cancer

NSABP Foundation Inc·interventional·Posted Feb 8, 2005·Updated Apr 14, 2022

In Brief

A clinical study evaluating 3-dimensional conformal accelerated partial breast irradiation, brachytherapy, and 2 other interventions for Breast Cancer. Completed, enrolled 4,216 participants across 387 sites in 4 countries.

Detailed Summary

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Giving radiation therapy in different ways may kill any tumor cells that remain after surgery. It is not yet known whether whole breast radiation therapy is more effective than partial breast radiation therapy in treating breast cancer. PURPOSE: This randomized phase III trial is studying whole breast radiation therapy to see how well it works compared to partial breast radiation therapy in treating women who have undergone surgery for ductal carcinoma in situ or stage I or stage II breast cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesCanada, Ireland, Israel, United States

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 8, 2005
Enrollment StartMar 1, 2005
Primary CompletionAug 1, 2018
TodayJul 1, 2026
Enrollment to primary: 13.4 yearsPosted 21.4 years ago

Interventions

3-dimensional conformal accelerated partial breast irradiationradiation

brachytherapyradiation

whole breast irradiationradiation

Patients undergo radiation therapy once daily (days 1-5) for up to 7 weeks

MammoSite or other single-entry intracavitary deviceradiation